Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Bristol-Myers Squibb |
---|---|
Information provided by: | Bristol-Myers Squibb |
ClinicalTrials.gov Identifier: | NCT00162448 |
Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Subjects with Implanted Dual-Chamber Pacemakers or Defibrillators
Condition | Intervention | Phase |
---|---|---|
Heart Diseases |
Drug: BMS-394136 Drug: Placebo |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety Study |
Official Title: | Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Patients With Implanted Dual-Chamber Pacemakers or Defibrillators |
Estimated Enrollment: | 36 |
Study Start Date: | January 2005 |
Arms | Assigned Interventions |
---|---|
A1: Experimental |
Drug: BMS-394136
Oral Solution, Oral, 100 mg, Single dose, 1 day.
|
A2: Placebo Comparator |
Drug: Placebo
Oral Solution, Oral, 0 mg, Single dose, 1 day.
|
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Maryland | |
Local Institution | |
Salisbury, Maryland, United States | |
United States, Michigan | |
Local Institution | |
Ann Arbor, Michigan, United States | |
United States, Ohio | |
Local Institution | |
Columbus, Ohio, United States |
Study ID Numbers: | CV175-003 |
Study First Received: | September 9, 2005 |
Last Updated: | August 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00162448 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Patients requiring dual-chamber pacemakers or defibrillators |
Heart Diseases |
Heart Diseases Cardiovascular Diseases |